Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

135.95
Delayed Data
As of Feb 20
 +0.84 / +0.62%
Today’s Change
13.09
Today|||52-Week Range
154.75
+48.11%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 153.00, with a high estimate of 170.00 and a low estimate of 140.00. The median estimate represents a +12.54% increase from the last price of 135.95.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.69
Sales
$0.00
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.47%
 
 
 
 
 
 
Growthannually 49.16%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.